THERAVANCE BIOPHARMA INC's ticker is TBPH and the CUSIP is G8807B106. A total of 108 filers reported holding THERAVANCE BIOPHARMA INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,475,195 | -21.8% | 170,938 | -6.2% | 0.00% | – |
| Q2 2023 | $1,886,391 | +24.0% | 182,260 | +29.9% | 0.00% | – |
| Q1 2023 | $1,521,832 | -5.4% | 140,261 | -2.2% | 0.00% | – |
| Q4 2022 | $1,609,307 | +4.8% | 143,432 | -5.3% | 0.00% | – |
| Q3 2022 | $1,536,000 | +15.0% | 151,510 | +2.7% | 0.00% | – |
| Q2 2022 | $1,336,000 | -5.8% | 147,468 | -0.6% | 0.00% | – |
| Q1 2022 | $1,419,000 | -35.2% | 148,387 | -25.1% | 0.00% | – |
| Q4 2021 | $2,189,000 | +18.2% | 198,054 | -20.8% | 0.00% | – |
| Q3 2021 | $1,852,000 | -98.5% | 250,219 | -97.1% | 0.00% | -100.0% |
| Q2 2021 | $126,720,000 | -16.8% | 8,727,324 | +16.9% | 0.02% | -22.2% |
| Q1 2021 | $152,346,000 | +56.8% | 7,464,202 | +36.5% | 0.03% | +50.0% |
| Q4 2020 | $97,154,000 | +39.0% | 5,467,300 | +15.6% | 0.02% | +28.6% |
| Q3 2020 | $69,898,000 | -25.7% | 4,727,592 | +5.5% | 0.01% | -33.3% |
| Q2 2020 | $94,093,000 | -2.3% | 4,482,777 | +7.6% | 0.02% | -16.0% |
| Q1 2020 | $96,312,000 | +17.1% | 4,167,523 | +31.2% | 0.02% | +47.1% |
| Q4 2019 | $82,267,000 | +1088.8% | 3,177,537 | +1564.1% | 0.02% | +750.0% |
| Q3 2016 | $6,920,000 | – | 190,950 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Madison Avenue Partners, LP | 7,012,226 | $60,515,510 | 8.59% |
| Irenic Capital Management LP | 2,760,948 | $23,826,981 | 6.76% |
| Newtyn Management, LLC | 1,841,560 | $15,892,663 | 3.92% |
| Weiss Asset Management LP | 7,457,060 | $64,354,428 | 3.81% |
| Park West Asset Management LLC | 1,983,251 | $17,115,456 | 1.57% |
| Baupost Group | 7,419,226 | $64,028 | 1.23% |
| Oasis Management Co Ltd. | 953,254 | $8,226,582 | 0.36% |
| Chescapmanager LLC | 287,333 | $2,479,684 | 0.32% |
| GSA CAPITAL PARTNERS LLP | 325,985 | $2,813 | 0.24% |
| Virtus ETF Advisers LLC | 29,232 | $252,272 | 0.15% |